{"id":"W2075141373","doi":"10.1200/jco.2008.17.1561","title":"Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Follicular lymphoma; Vincristine; Rituximab; Internal medicine; Hazard ratio; Prednisone; Lymphoma; Cyclophosphamide; International Prognostic Index; Gastroenterology; Chemotherapy; Surgery; Oncology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002127569,0.0007694689,0.001852574,0.0002355473,0.0002026582,0.0005181995,0.0008097193,0.0008230504,0.001545299],"category_scores_gemma":[0.001247362,0.0002622551,0.00103344,0.0002630509,0.0005650066,0.0004178074,0.0002112717,0.001362458,0.0002821104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006174651,"about_ca_system_score_gemma":0.0005276169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00069723,"about_ca_topic_score_gemma":0.001580853,"domain_scores_codex":[0.9992643,0.0004992429,0.00003445886,0.00007103774,0.00006534088,0.0000656289],"domain_scores_gemma":[0.9989938,0.0002587676,0.0003112231,0.00008999663,0.00004151846,0.0003046481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8899924,0.008374341,0.01121014,0.0004327268,0.00174964,0.000103392,0.00007203047,0.0009131344,0.009953719,0.00006655989,0.001659618,0.07547225],"study_design_scores_gemma":[0.6968284,0.2490032,0.04814765,0.00006625059,0.001396905,0.0002829058,0.00002680777,0.001099647,0.001315428,0.000119572,0.001689858,0.00002341609],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959434,0.002768172,0.0002004804,0.0001467141,0.00004760716,0.0002821146,0.0002298693,0.00003101995,0.0003506019],"genre_scores_gemma":[0.9955137,0.001687084,0.0006164694,0.0003977378,0.0001320786,0.0004344529,0.0007573492,0.00001071932,0.000450339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002127569,"threshold_uncertainty_score":0.01125181,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02955410953605098,"score_gpt":0.4113715754994215,"score_spread":0.3818174659633706,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}